Welcome to the January 2026 issue of Regulatory Rapporteur which focuses on complex products.

Innovation across medicines, medical devices and enabling technologies continues to accelerate, often moving faster than the regulatory frameworks designed to assure patient safety, product quality and public trust. The articles in this exciting January issue of Regulatory Rapporteur explore how regulators, developers and regulatory professionals are responding to this challenge – not by slowing innovation, but by shaping proportionate, adaptive and confidence-based regulatory pathways.